PACIRA BIOSCIENCES, INC. Total Long-Term Debt
PACIRA BIOSCIENCES, INC. (PCRX) had Total Long-Term Debt of $363.12 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-08-04
- 2026-06-30: Long-term Debt $363.12M.
- 2026-03-31: Long-term Debt $367.66M.
- 2025-12-31: Long-term Debt $372.19M.
- 2025-09-30: Long-term Debt $376.72M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2026-06-30 | $363.12M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $367.66M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $372.19M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $376.72M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $580.49M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $583.38M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $585.32M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $522.44M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $689.47M 10-K · filed 2024-02-29 | |
| 2016-12-31 | $108.74M 10-K · filed 2017-03-01 | |
| 2016-09-30 | $107.56M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $106.39M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $105.22M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $104.04M 10-K · filed 2017-03-01 | $105.93M 10-K · filed 2016-02-25 |
| 2015-09-30 | $104.91M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $103.89M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $104.14M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $103.10M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $102.06M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $101.03M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $100.00M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $98.96M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $97.93M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $96.89M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $95.86M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $25.19M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $27.50M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $27.50M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $25.58M 10-K · filed 2013-03-07 | $19.21M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |